Financials data is unavailable for this security.
View more
Year on year Diaceutics PLC 's net income fell from a gain of 724.00k to a loss of 1.75m despite revenues that grew 21.51% from 19.50m to 23.70m. An increase in the selling, general and administrative costs as a percentage of sales from 83.47% to 96.14% was a component in the falling net income despite rising revenues.
Gross margin | 83.15% |
---|---|
Net profit margin | -7.37% |
Operating margin | -12.73% |
Return on assets | -4.19% |
---|---|
Return on equity | -4.72% |
Return on investment | -4.53% |
More ▼
Cash flow in GBPView more
In 2023, cash reserves at Diaceutics PLC fell by 3.17m. However, the company earned 1.31m from its operations for a Cash Flow Margin of 5.53%. In addition the company used 4.21m on investing activities and also paid 239.00k in financing cash flows.
Cash flow per share | 0.0359 |
---|---|
Price/Cash flow per share | 36.24 |
Book value per share | 0.3719 |
---|---|
Tangible book value per share | 0.2675 |
More ▼
Balance sheet in GBPView more
Current ratio | 8.84 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.0384 |
---|---|
Total debt/total capital | 0.0369 |
More ▼
Growth rates in GBP
Year on year, growth in earnings per share excluding extraordinary items dropped -346.49%.
EPS growth(5 years) | -- |
---|---|
EPS (TTM) vs TTM 1 year ago | -364.92 |